| Literature DB >> 32737706 |
M Ceresoli1, F Carissimi2, A Nigro2, P Fransvea3, L Lepre4, M Braga2, G Costa5.
Abstract
PURPOSE: The incidence of inguinal hernia is higher in elderly because of aging-related diseases like prostatism, bronchitis, collagen laxity. A conservative management is common in elderly to reduce surgery-related risks, however watchful waiting can expose to obstruction and strangulation. The aim of the present study was to assess the impact of emergency surgery in a large series of elderly with complicated groin hernia and to identify the independent risk factors for postoperative morbidity and mortality. The predictive performance of prognostic risk scores has been also assessed.Entities:
Keywords: Charlson’s comorbidity index; Elderly; Emergency surgery; Groin hernia; Incarcerated hernia; Postoperative complications
Mesh:
Year: 2020 PMID: 32737706 PMCID: PMC8881429 DOI: 10.1007/s10029-020-02269-5
Source DB: PubMed Journal: Hernia ISSN: 1248-9204 Impact factor: 2.920
Patients characteristics
| Mean (SD) | Median (IQR) | % | ||
|---|---|---|---|---|
| Number of patients | 259 | |||
| Age | 79.70 (8.37) | 79 (73–87) | ||
| Age class | ||||
| 65–70 | 41 | 15.1% | ||
| 71–75 | 49 | 18.3% | ||
| 76–80 | 51 | 19.7% | ||
| 81–85 | 39 | 15.1% | ||
| 86–90 | 51 | 19.7% | ||
| > 90 | 28 | 10.8% | ||
| Sex | ||||
| Female | 109 | 42.1% | ||
| Male | 150 | 57.9% | ||
| BMI | 25.36 (5.67) | 24.74 (22–27) | ||
| Mental status impairment | 14 | 6.3% | ||
| Hypotension (SBP < 90) | 3 | 1.2% | ||
| Tachycardia (HR > 100) | 14 | 5.4% | ||
| Comorbidity | ||||
| Atrial Fibrillation/arrhythmia | 96 | 37.1% | ||
| Ischemic heart disease | 8 | 3.1% | ||
| Chronic heart disease | 73 | 28.2% | ||
| Arterial hypertension | 168 | 64.9% | ||
| Peripheral artery disease | 37 | 14.3% | ||
| Cerebrovascular disease | 38 | 14.7% | ||
| Oral Anticoagulants | 52 | 20.1% | ||
| COPD | 48 | 18.5% | ||
| Metastatic Cancer | 9 | 3.5% | ||
| Cancer without metastasis | 23 | 8.9% | ||
| Leukemia/lymphoma | 7 | 2.7% | ||
| Hepatic disease | 10 | 3.9% | ||
| Kidney disease | 22 | 8.5% | ||
| Diabetes | 32 | 16.2% | ||
| Peptic ulcer | 6 | 2.3% | ||
| Connective tissue disease | 10 | 3.9% | ||
| Steroids/immunosuppressive | 14 | 5.4% | ||
| Emiplegia | 10 | 3.9% | ||
| Demenza | 27 | 10.4% | ||
| ASA score | ||||
| 1 | 12 | 4.7% | ||
| 2 | 88 | 34.8% | ||
| 3 | 132 | 52.2% | ||
| 4 | 20 | 7.9% | ||
| 5 | 1 | 0.4% | ||
| Charlson comorbidity index | 4.97 (2.28) | 4 (3–6) | ||
| Charlson comorbidity index | ||||
| < 6 | 176 | 68% | ||
| ≥ 6 | 83 | 32% | ||
| Charlson comorbidity index | ||||
| 0–1 | 0 | 0% | ||
| 2–3 | 71 | 27% | ||
| 4–5 | 105 | 40.5% | ||
| 6–7 | 46 | 17.8% | ||
| 8–9 | 28 | 10.8% | ||
| 10–11 | 5 | 1.9% | ||
| 12–13 | 2 | 0.8% | ||
| 14–15 | 1 | 0.4% | ||
| 16–17 | 1 | 0.4% | ||
| Predicted mortality risk (PPOSSUM) | 7.81 (12.46) | 3.60 (1.5–8.1) | ||
| Predicted morbidity risk (PPOSSUM) | 50.68 (24.11) | 49 (29–71) | ||
| Predicted mortality risk (CR-POSSUM) | 6.88 (7.34) | 5.10 (1.9–9) | ||
Surgery data and outcomes
| Mean (SD) | Median (IQR) | % | ||
|---|---|---|---|---|
| Time to surgery (days) | 0.58 (1.49) | 0 (0–1) | ||
| Kind of hernia | ||||
| Inguinal | 180 | 69.11% | ||
| Femoral | 79 | 30.12% | ||
| Inguinal hernia | ||||
| Direct repair | 15 | 8.33% | ||
| Mesh | 165 | 91.67% | ||
| Femoral hernia | ||||
| Direct repair | 47 | 59.49% | ||
| Mesh | 32 | 40.51% | ||
| Laparoscopic repair | 10 | 12.66% | ||
| Explorative laparotomy/laparoscopy | 56 | 21.62% | ||
| Intestinal resection | ||||
| No | 215 | 83.01% | ||
| Colon | 2 | 0.77% | ||
| Ileum | 41 | 15.83% | ||
| Ileum-cecum | 1 | 0.39% | ||
| Length of stay | 5.17 (4.02) | 4.00 (2.00–7.00) | ||
| Reintervention | 3 | 1.16% | ||
| Major complications | 12 | 4.63% | ||
| Complications | 55 | 21.24% | ||
| Perforation | 2 | 0.77% | ||
| Occlusion | 5 | 1.93% | ||
| Pneumonia | 8 | 3.09% | ||
| Acute renal failure | 4 | 1.54% | ||
| Bleeding | 5 | 1.93% | ||
| Stroke | 2 | 0.77% | ||
| Acute myocardial infarction/heart failure | 3 | 1.16% | ||
| Arrhythmia | 5 | 1.93% | ||
| SSI | 6 | 2.32% | ||
| Mortality | 7 | 2.70% | ||
Univariate and multivariate analysis of factor associated to laparotomy and resection
| laparotomy | Resection | |||||||
|---|---|---|---|---|---|---|---|---|
| OR (95% CI) univariate | OR (95% CI) multivariate | OR (95% CI) univariate | OR (95% CI) multivariate | |||||
| Age | 1.006 (0.971–1.042) | 0.736 | 0.984 (0.948–1.022) | 0.399 | ||||
| BMI | 0.974 (0.906–1.048) | 0.482 | 0.941 (0.859–1.031) | 0.193 | ||||
| Male sex | 0.606 (0.334–1.098) | 0.097 | 0.784 (0.42–1.464) | 0.445 | ||||
| ASA ≥ 3 | 1.94 (0.991–3.831) | 0.051 | ||||||
| Charlson ≥ 6 | 1.66 (0.901–3.065) | 0.102 | 1.44 (0.758–2.754) | 0.262 | ||||
| Femoral Hernia (inguinal ref) | 1.830 (0.989–3.384) | 0.052 | ||||||
| Arrhythmia | 1.241 (0.678–2.227) | 0.483 | 1.216 (0.644–2.296) | 0.546 | ||||
| Myocardial infarction | 1.216 (0.239–6.196) | 0.814 | 1.447 (0.283–7.395) | 0.656 | ||||
| Chronic heart disease | 2.260 (0.577–8.846) | 0.242 | 3.022 (0.819–11.153) | 0.083 | ||||
| Hypertension | 0.858 (0.464–1.586) | 0.625 | 0.652 (0.346–1.231) | 0.186 | ||||
| Cerebrovascular disease | 1.359 (0.616–2.999) | 0.447 | 0.776 (0.305–1.974) | 0.594 | ||||
| Oral anticoagulants | 1.11 (0.538–2.297) | 0.776 | 1.193 (0.562–2.533) | 0.645 | ||||
| Chronic lung diseases | 1.657 (0.816–3.364) | 0.159 | 1.568 (0.745–3.279) | 0.233 | ||||
| Metastatic solid tumors | 1.858 (0.45–7.679) | 0.385 | ||||||
| Non-metastatic solid tumors | 0.745 (0.243–2.286) | 0.606 | 0.62 (0.177–2.1734) | 0.451 | ||||
| Liver disease | 0.903 (0.186–4.376) | 0.899 | 1.891 (0.471–7.592) | 0.362 | ||||
| Kidney disease | 1.073 (0.378–3.047) | 0.895 | 0.948 (0.306–2.938) | 0.926 | ||||
| Diabetes | 0.440 (0.164–1.178) | 0.095 | 0.402 (0.136–1.186) | 0.089 | ||||
| Steroids/immunosoppressors | 1.485 (0.447–4.926) | 0.516 | 2.538 (0.811–7.942) | 0.099 | ||||
| Dementia | 2.051 (0.841–5.001) | 0.114 | 1.961 (0.804–4.787) | 0.133 | ||||
| Leukemia/lymphoma | 0.597 (0.07–5.064) | 0.633 | 1.745 (0.328–9.270) | 0.509 | ||||
Bold indicate depicted significative results
Prognostic score assessment and distribution among patients
| Complications | Major complications | Mortality | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| No | Complicated | None | Complicated | Alive | Dead | ||||||||||
| %/(SD) | %/(SD) | %/(SD) | %/(SD) | %/(SD) | %/(SD) | ||||||||||
| ASA score | |||||||||||||||
| Mean | 2.59 | 0.70 | 2.84 | 0.74 | 0.024 | 2.62 | 0.69 | 3.08 | 1.00 | 0.024 | 2.61 | 0.69 | 3.57 | 0.98 | < 0.001 |
| ASA score | |||||||||||||||
| 1 | 11 | 91.7% | 1 | 8.3% | 0.105 | 12 | 100.0% | 0 | 0.0% | < 0.001 | 12 | 100.0% | 0 | 0.0% | < 0.001 |
| 2 | 72 | 81.8% | 16 | 18.2% | 84 | 95.5% | 4 | 4.5% | 85 | 98.8% | 1 | 1.2% | |||
| 3 | 102 | 77.3% | 30 | 22.7% | 128 | 97.0% | 4 | 3.0% | 126 | 98.4% | 2 | 1.6% | |||
| 4 | 13 | 65.0% | 7 | 35.0% | 17 | 85.0% | 3 | 15.0% | 16 | 84.2% | 3 | 15.8% | |||
| 5 | 0 | 0.0% | 1 | 100.0% | 0 | 0.0% | 1 | 100.0% | 0 | 0.0% | 1 | 100.0% | |||
| ASA score | |||||||||||||||
| < 3 | 89 | 84.0% | 17 | 16.0% | 0.089 | 102 | 96.2% | 4 | 3.8% | 0.584 | 103 | 99.0% | 1 | 1.0% | 0.141 |
| ≥ 3 | 115 | 75.2% | 38 | 24.8% | 145 | 94.8% | 8 | 5.2% | 142 | 95.9% | 6 | 4.1% | |||
| CHARLSON | |||||||||||||||
| Mean | 4.78 | 2.05 | 5.76 | 2.76 | 0.004 | 4.91 | 2.11 | 6.67 | 3.98 | 0.008 | 4.92 | 2.11 | 8.86 | 3.85 | < 0.001 |
| Charlson comorbidity index | |||||||||||||||
| < 6 | 146 | 83.0% | 30 | 17.0% | 0.016 | 171 | 97.2% | 5 | 2.8% | 0.046 | 169 | 100.0% | 0 | 0.0% | < 0,001 |
| ≥ 6 | 58 | 69.9% | 25 | 30.1% | 76 | 91.6% | 7 | 8.4% | 76 | 91.6% | 7 | 8.4% | |||
| Charlson comorbidity index | |||||||||||||||
| 1–2-Jan | 60 | 84.5% | 11 | 15.5% | 0.153 | 69 | 97.2% | 2 | 2.8% | < 0.001 | 67 | 100.0% | 0 | 0.0% | < 0.001 |
| 4–5-Apr | 86 | 81.9% | 19 | 18.1% | 102 | 97.1% | 3 | 2.9% | 102 | 100.0% | 0 | 0.0% | |||
| 6–7-Jun | 34 | 73.9% | 12 | 26.1% | 43 | 93.5% | 3 | 6.5% | 43 | 93.5% | 3 | 6.5% | |||
| 8–9-Aug | 19 | 67.9% | 9 | 32.1% | 26 | 92.9% | 2 | 7.1% | 26 | 92.9% | 2 | 7.1% | |||
| 10–11-Oct | 3 | 60.0% | 2 | 40.0% | 4 | 80.0% | 1 | 20.0% | 4 | 80.0% | 1 | 20.0% | |||
| 12–13-Dec | 1 | 50.0% | 1 | 50.0% | 2 | 100.0% | 0 | 0.0% | 2 | 100.0% | 0 | 0.0% | |||
| 14–15 | 1 | 100.0% | 0 | 0.0% | 1 | 100.0% | 0 | 0.0% | 1 | 100.0% | 0 | 0.0% | |||
| 16–17 | 0 | 0.0% | 1 | 100.0% | 0 | 0.0% | 1 | 100.0% | 0 | 0.0% | 1 | 100.0% | |||
| LOS | 4.30 | 3.25 | 8.38 | 4.88 | < 0.001 | 4.93 | 3.63 | 10.00 | 7.54 | < 0.001 | 5.00 | 3.80 | 11.57 | 7.18 | < 0.001 |
| Predicted mortality risk (PPOSSUM) (mean) | 7.18 | 10.91 | 30.70 | 33.30 | < 0.001 | ||||||||||
| Predicted morbidity risk (PPOSSUM) (mean) | 46.97 | 22.41 | 64.43 | 25.41 | < 0.001 | 49.98 | 23.85 | 64.96 | 26.01 | 0.035 | |||||
| Predicted mortality risk (CR-POSSUM) (mean) | 6.63 | 7.00 | 17.07 | 13.74 | < 0.001 | ||||||||||
Univariate and multivariate analysis for complications and mortality
| Complication | Major complication | Mortality | ||||||
|---|---|---|---|---|---|---|---|---|
| OR (95% CI) univariate | OR (95% CI) multivariate | OR (95%CI) univariate | OR (95%CI) univariate | |||||
| Age | 1.010 (0.974–1.046) | 0.594 | 0.959 (0.892–1.031) | 0.256 | 1.019 (0.931–1.115) | 0.69 | ||
| BMI | 0.968 (0.902–1.032) | 0.364 | 0.924 (0.784–1.089) | 0.347 | 0.842 (0.687–1.031) | 0.096 | ||
| hypotension | 7.843 (0.678–88.20) | 0.051 | ||||||
| Tachycardia | 2.889 (0.673–12.40) | 0.154 | ||||||
| Mental impairment | 2.502 (0.626–9.993) | 0.194 | ||||||
| Male Sex | 0.635 (0.349–1.155) | 0.135 | 1.018 (0.314–3.297) | 0.976 | 1.875 (0.357–9.854) | 0.451 | ||
| ASA ≥ 3 | 1.730 (0.916–3.265) | 0.089 | 1.407 (0.413–4.797) | 0.584 | 4.352 (0.516–36.70) | 0.141 | ||
| Charlson ≥ 6 | 1.105 (0.624–1.956) | 0.732 | ||||||
| Crural hernia | 1.404 (0.750–2.630) | 0.287 | 1.147 (0.335–3.925) | 0.827 | 0.889 (0.169–4.687) | 0.89 | ||
| Laparotomy | ||||||||
| Prosthesis | 0.795 (0.433–1.46) | 0.46 | 1.008 (0.285–3.571) | 0.99 | 1.034 (0.205–5.223) | 0.968 | ||
| Bowel resection | 0.721 (0.193–3.165) | 0.728 | ||||||
| Arrhythmia | 1.224 (.0378–3.971) | 0.735 | 1.247 (0.273–5.698) | 0.775 | ||||
| Ischemic heart disease | 2.296 (0.531–9.922) | 0.253 | ||||||
| Chronic heart disease | 2.588 (0.704–9.516) | 0.139 | ||||||
| Hypertension | 1.739 (0.890–3.397) | 0.103 | 2.767 (0.593–12.91) | 0.178 | 3.188 (0.378–26.91) | 0.261 | ||
| cerebrovascular disease | 1.181 (0.522–2.668) | 0.689 | 1.172 (0.247–5.572) | 0.841 | 2.322 (0.434–12.42) | 0.312 | ||
| Oral anticoagulants | 1.915 (0.966–3.795) | 0.06 | 3.04 (0.924–9.999) | 0.056 | ||||
| COPD | 3.426 (0.74–15.855) | 0.095 | ||||||
| Metastatic solid tumors | 1.904 (0.461–7.87) | 0.366 | 2.716 (0.312–23.666) | 0.347 | 4.938 (0.53–45.972) | 0.121 | ||
| Non-metastatic solid tumors | 1.347 (0.504–3.598) | 0.551 | 2.152 (0.442–10.478) | 0.332 | 4.5 (0.82–24.692) | 0.059 | ||
| Liver disease | 0.401 (0.05–3.237) | 0.376 | – | 0.477 | – | 0.606 | ||
| Kidney disease | 1.838 (0.71–4.758) | 0.205 | 2.27 (0.465–11.082) | 0.298 | 4.5 (0.82–24.692) | 0.59 | ||
| Diabetes | 1.868 (0.895–3.898) | 0.093 | 1.778 (0.461–6.862) | 0.398 | 4.086 (0.879–18.98) | 0.053 | ||
| Immunosuppressive drugs | 3.684 (0.941–14.42) | 0.061 | 1.636 (0.196–3.659) | 0.646 | 2.974 (0.333–26.562) | 0.306 | ||
| Dementia | 2.022 (0.853–4.791) | 0.104 | ||||||
| Leukemia/lymphoma | 0.611 (0.072–5.185) | 0.649 | 3.652 (0.404–33.006) | 0.218 | 6.639 (0.688–64.05) | 0.06 | ||
Fig. 1a complications, major complications and mortality rates among ASA score (a) and Charlson’s comorbidity index (b) classes